10X Genomics Inc
10X Genomics Inc is a genomics company that develops gene-sequencing technologies.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying 10X Genomics stock with a target price of $38.77, indicating strong growth potential.
Financial Health
10X Genomics Inc is showing strong revenue and profit margins, indicating a healthy business performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring TXG
Activist Sparks Life Science Shakeup
Activist investor Engine Capital is pushing for a sale of life-sciences company Avantor after taking a significant stake. This move could spark a wave of M&A across the life-sciences supply industry, creating opportunities for competitor firms and other potential acquisition targets.
Published: August 11, 2025
Explore BasketPatient Platforms
This carefully curated collection features companies building the technological foundations that will power innovation for decades to come. Our analysts have identified businesses creating essential infrastructure in genomics, AI, robotics, and advanced computing—platforms that could define their industries and generate substantial long-term returns.
Published: June 17, 2025
Explore BasketNew Moon Portfolio
This collection represents the very beginning of the next technological cycle. These carefully selected companies are sowing the seeds of future industries, giving you early exposure to disruptive innovators poised for exponential growth as their technologies reshape our world.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Recurring Consumables
Revenue from reagents and software can give a recurring stream as the installed base grows, though sales depend on research funding and competitive dynamics.
Expanding Applications
Single‑cell and spatial techniques are finding wider use across oncology and cell therapy discovery, presenting long‑term opportunity while adoption may take time.
Execution & Cash
Execution on product launches and margin improvement matters; the company’s investment focus has previously impacted short‑term profitability and cash flow.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Thermo Fisher Scientific, Inc.
Thermo Fisher provides a range of services and products that help customers advance their research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.
Intuitive Surgical, Inc.
A healthcare company that develops, manufactures, and markets robotic-assisted surgical systems for procedures in multiple specialties
